Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Discover why this innovative peptide is becoming a preferred choice for research relating to: Tri-agonist targeting GLP-1, GIP, and glucagon Weight management Insulin sensitivity and glucose control Metabolic efficiency Additional Information Retatrutide has shown promising results in human trials
In the study Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin , it was found that providing calcium supplementation to people taking metformin, was able to help prevent metformin-induced vitamin B12 deficiency
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Complete peptide list catalogs available compounds with brief descriptions of each
Bales 2013
White Label Formula
US$ 28.46
US$ 24.72
US$ 25.66
US$ 27.01
US$ 26.21
